1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 43, 26/Oct/2017
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.43.17-00707
2017-10-26
2024-11-21
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.43.17-00707
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/43/eurosurv-22-43-1.html?itemId=/content/10.2807/1560-7917.ES.2017.22.43.17-00707&mimeType=html&fmt=ahah

References

  1. Australian Government. Department of Health. Australian Influenza Surveillance Report No 10 – week ending 29 September 2017. Canberra: Department of Health; 2017. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/ozflu-surveil-no10-17.htm
  2. NSW Government. Health. Influenza Surveillance Report, Week 39: 25 September to 1 October 2017. North Sydney: NSW Government. [Accessed 25 Oct 2017]. Available from: http://www.health.nsw.gov.au/Infectious/Influenza/Publications/2017/weekending-01102017.pdf
  3. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season. Geneva: WHO; 29 Sep 2016. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2017_south/en/
  4. Australian Government. Department of Health. Therapeutic Goods Administration. 2017 seasonal influenza vaccines. Symonston: Therapeutic Goods Administration; 6 Mar 2017. Available from: https://www.tga.gov.au/media-release/2017-seasonal-influenza-vaccines
  5. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2017-2018 northern hemisphere influenza season. Geneva: WHO; 2017. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2017_18_north/en/
  6. Fielding JE, Levy A, Chilver MB, Deng YM, Regan AK, Grant KA, et al. Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment. Vaccine. 2016;34(41):4905-12.  https://doi.org/10.1016/j.vaccine.2016.08.067  PMID: 27577556 
  7. Sullivan SG, Carville KS, Chilver M, Fielding JE, Grant KA, Kelly H, et al. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. Epidemiol Infect. 2016;144(11):2317-28.  https://doi.org/10.1017/S0950268816000819  PMID: 27125368 
  8. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972;70(4):767-77.  https://doi.org/10.1017/S0022172400022610  PMID: 4509641 
  9. Lin Y, Gu Y, McCauley JW. Optimization of a Quantitative Micro-neutralization Assay. J Vis Exp. 2016; (118).  https://doi.org/10.3791/54897  PMID: 28060291 
  10. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31(30):3104-9.  https://doi.org/10.1016/j.vaccine.2013.04.026  PMID: 23624093 
  11. Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ. Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness. Am J Epidemiol. 2016;184(5):345-53.  https://doi.org/10.1093/aje/kww064  PMID: 27587721 
  12. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season. Geneva: WHO; 24 Sep 2015. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2016_south/en/
  13. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. Geneva: WHO; 25 Feb 2016. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2016_17_north/en/
  14. Castilla J, Navascués A, Casado I, Díaz-González J, Pérez-García A, Fernandino L, et al. Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis. Euro Surveill. 2017;22(7):30465.  https://doi.org/10.2807/1560-7917.ES.2017.22.7.30465  PMID: 28230523 
  15. Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, et al. Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. MMWR Morb Mortal Wkly Rep. 2017;66(6):167-71.  https://doi.org/10.15585/mmwr.mm6606a3  PMID: 28207689 
  16. Kissling E, Rondy MI-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 2017;22(7):30464.  https://doi.org/10.2807/1560-7917.ES.2017.22.7.30464  PMID: 28230524 
  17. Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, et al. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro Surveill. 2017;22(6):30460. . Available from: https://doi.org/10.2807/1560-7917.ES.2017.22.6.30460 https://doi.org/10.2807/1560-7917.ES.2017.22.6.30460  PMID: 28205503 
  18. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA. 1999;96(24):14001-6.  https://doi.org/10.1073/pnas.96.24.14001  PMID: 10570188 
  19. Leung VK, Cowling BJ, Feng S, Sullivan SG. Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review. Euro Surveill. 2016;21(16):30202.  https://doi.org/10.2807/1560-7917.ES.2016.21.16.30202  PMID: 27124573 
  20. Sullivan SG, Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. Euro Surveill. 2013;18(41):20605.  https://doi.org/10.2807/1560-7917.ES2013.18.41.20605  PMID: 24135124 
  21. Pan American Health Organization (PAHO). Weekly Influenza Report EW 39. Washington: PAHO; 11 Oct 2017. Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=42470&lang=en
  22. World Health Organization (WHO). A manual for estimating disease burden associated with seasonal influenza. Geneva: WHO; 2015. Available from: http://www.who.int/influenza/resources/publications/manual_burden_of_disease/en/
Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Sheena+G+Sullivan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sullivan Sheena G</a>, <a href="/search?value1=Monique+B+Chilver&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Chilver Monique B</a>, <a href="/search?value1=Kylie+S+Carville&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Carville Kylie S</a>, <a href="/search?value1=Yi-Mo+Deng&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Deng Yi-Mo</a>, <a href="/search?value1=Kristina+A+Grant&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Grant Kristina A</a>, <a href="/search?value1=Geoff+Higgins&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Higgins Geoff</a>, <a href="/search?value1=Naomi+Komadina&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Komadina Naomi</a>, <a href="/search?value1=Vivian+KY+Leung&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Leung Vivian KY</a>, <a href="/search?value1=Cara+A+Minney-Smith&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Minney-Smith Cara A</a>, <a href="/search?value1=Don+Teng&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Teng Don</a>, <a href="/search?value1=Thomas+Tran&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Tran Thomas</a>, <a href="/search?value1=Nigel+Stocks&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stocks Nigel</a>, <a href="/search?value1=James+E+Fielding&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Fielding James E</a></span>. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. <a href="/content/ecdc">Euro Surveill.</a> 2017;22(43):pii=17-00707. <a href="https://doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 19 Oct 2017;&nbsp;&nbsp; <span class="generated">Accepted</span>: 26 Oct 2017 </span> </p>
/content/10.2807/1560-7917.ES.2017.22.43.17-00707
/content/10.2807/1560-7917.ES.2017.22.43.17-00707
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error